🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.155
-0.025 (-2.12%)
Nov 18, 2026, 1:21 PM EST - Market open

Gain Therapeutics Statistics

Total Valuation

GANX has a market cap or net worth of $51.43 million. The enterprise value is $40.41 million.

Market Cap51.43M
Enterprise Value 40.41M

Important Dates

The last earnings date was Tuesday, November 10, 2026, before market open.

Earnings Date Nov 10, 2026
Ex-Dividend Date n/a

Share Statistics

GANX has 44.53 million shares outstanding. The number of shares has increased by 36.92% in one year.

Current Share Class 44.53M
Shares Outstanding 44.53M
Shares Change (YoY) +36.92%
Shares Change (QoQ) +2.08%
Owned by Insiders (%) 2.27%
Owned by Institutions (%) 19.58%
Float 42.63M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 5.15
P/TBV Ratio 5.17
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.36, with a Debt / Equity ratio of 0.07.

Current Ratio 5.36
Quick Ratio 5.07
Debt / Equity 0.07
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -223.94% and return on invested capital (ROIC) is -127.64%.

Return on Equity (ROE) -223.94%
Return on Assets (ROA) -91.45%
Return on Invested Capital (ROIC) -127.64%
Return on Capital Employed (ROCE) -163.01%
Weighted Average Cost of Capital (WACC) 5.80%
Revenue Per Employee n/a
Profits Per Employee -$856,300
Employee Count21
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, GANX has paid $429,741 in taxes.

Income Tax 429,741
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -58.16% in the last 52 weeks. The beta is 0.30, so GANX's price volatility has been lower than the market average.

Beta (5Y) 0.30
52-Week Price Change -58.16%
50-Day Moving Average 1.43
200-Day Moving Average 1.81
Relative Strength Index (RSI) 48.27
Average Volume (20 Days) 734,978

Short Selling Information

The latest short interest is 3.89 million, so 8.74% of the outstanding shares have been sold short.

Short Interest 3.89M
Short Previous Month 3.19M
Short % of Shares Out 8.74%
Short % of Float 9.13%
Short Ratio (days to cover) 6.39

Income Statement

Revenue n/a
Gross Profit -8.57M
Operating Income -17.71M
Pretax Income -17.55M
Net Income -17.98M
EBITDA -17.66M
EBIT -17.71M
Earnings Per Share (EPS) -$0.43
Full Income Statement

Balance Sheet

The company has $11.70 million in cash and $676,706 in debt, with a net cash position of $11.02 million or $0.25 per share.

Cash & Cash Equivalents 11.70M
Total Debt 676,706
Net Cash 11.02M
Net Cash Per Share $0.25
Equity (Book Value) 10.15M
Book Value Per Share 0.23
Working Capital 10.33M
Full Balance Sheet

Cash Flow

Operating Cash Flow -17.07M
Capital Expenditures n/a
Depreciation & Amortization 46,965
Net Borrowing -100,464
Free Cash Flow -17.07M
FCF Per Share -$0.38
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

GANX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -36.92%
Shareholder Yield -36.92%
Earnings Yield -37.35%
FCF Yield -32.77%

Analyst Forecast

The average price target for GANX is $6.60, which is 471.43% higher than the current price. The consensus rating is "Strong Buy".

Price Target $6.60
Price Target Difference 471.43%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 3